Bilal Coulibaly Goes Un-extended: The 72% Problem and a $10.3M Matching Right

The rookie-scale extension deadline closed in Washington this Monday without a single announcement. No signature, no joint statement, no handshake in front of cameras. Bilal Coulibaly enters the fourth year of his rookie deal carrying $9.2 million in its final season, and in the summer of 2027 he will hit restricted free agency. I spent three nights rewinding tape from three of Coulibaly's games last season. Not hunting highlights. Hunting the opposite: possessions where the opposing defense deliberately left him outside the arc, possessions where the ball swung to his hands and he sent it back. Some nights he touched the ball forty times without once forcing a timeout. Washington handled this deadline with a very sober calculation: they bought one more season of information, and they paid for it with certainty about price. To understand why, you have to read the mechanics before you read the commentary. Coulibaly arrived in the NBA in 2026 from Metropolitans 92, alongside Victor Wembanyama, and already had a place in the French national team. Three seasons in Washington: 178 games, 10.8 points per game. Last season he started 56 games. The mechanism is straightforward. A first-round pick reaching the end of Year 4 becomes a restricted free agent unless the team extends him before the deadline. Washington let the deadline pass. That makes them the only team able to grant him a fifth year via extension, and they chose not to use that lever. In exchange, they keep the right to match any outside offer sheet, conditional on tendering a $10.3 million qualifying offer. From an asset-management standpoint, this is a decision to defer, not a decision born of fear. Washington sits inside a rebuild, with cap flexibility, and its single greatest strategic asset is cheap rookie-scale contracts. Pushing a player into RFA is how you keep him one more season below market, trading that against the risk of another team setting his price. But I don't want to stop there. There is something in this equation nobody bothers to compute. Three NBA seasons means 246 scheduled games. Coulibaly played 178. Divide it out: 72%. From the data dump, I pulled out the gem the basketball world left behind. The 72% figure appears in no news item. It exists only as a descriptive sentence: injuries shortened his first three seasons. Written as a sentence, it sounds like sympathy. Written as a rate, it is a red flag. For a player whose primary value is perimeter defense — the skill that decays fastest when lower-body injuries recur — a 72% availability rate is a valuation problem, not a medical one. Any team weighing an offer sheet looks at that number before it looks at scoring average. Now the scoring average. 10.8 points across 178 games, at 23, on a team that lost sixty games. A high-touch player on a losing team inflates volume without needing efficiency to follow. The original piece supplies no efficiency metric at all: no TS%, no eFG%, no three-point rate, no on/off, no usage. Without usage, 10.8 points cannot be converted into value. Without on/off, there is no way to know whether his defense actually lifts the team's net rating or merely lives in reputation. The silence on three-point percentage is the most readable clue in the whole piece. An article that frames market value directly and never once mentions the jump shot usually does so because the jump shot offers nothing to mention. If he had improved it, the agent would have placed it in paragraph two. This is where I feel my own trade being tested. Lozano taught me: a wrong name can be fixed, a wrong tactical read is paid for in losses. Applied here: calling Coulibaly a reliable perimeter defender is easy, but pricing him off that label alone is wrong. This archetype — long, switchable, defense first and offense second — sits exactly at the intersection of two opposing curves. Versatile defense is the scarcest commodity in today's league. Half-court offense without a jump shot is the most oversupplied. His price is set not by production but by that structural position. Look across the 2026 draft comparables — Anthony Black, Scoot Henderson, Noah Clowney, Dereck Lively II, Jaime Jaquez Jr., Brice Sensabaugh — and the market tiers cleanly. The Herbert Jones and Josh Green tier, roughly $13 to $18 million per year, belongs to good defensive wings with a tolerable shot. The Dyson Daniels tier, $25 million and up, demands demonstrated shooting improvement. Nothing in the original piece pushes Coulibaly into the upper tier. One technical detail is worth recording. The standard qualifying offer formula for a first-round pick completing Year 4 is 125% of the prior-year salary. 125% of $9.2 million is $11.5 million. The article states $10.3 million. That is a gap of roughly 12%. Possible explanations: the $9.2 million includes unlikely bonuses excluded from the computation, a starter-criteria recalculation applies, or one of the two figures is simply wrong. Cross-checking the published 2026 rookie scale for a mid-lottery slot puts the Year 4 salary nearer $8 million. The article also never states his draft position — a conspicuous omission in a piece about contract mechanics. In other words, the mechanics are credible; the valuation is blurry. This is a salary-cap article wearing a player-profile costume. The consensus will read the non-extension as a downgrade signal. I read it the other way, and I place my bet one beat earlier. For Coulibaly, RFA is the better path than signing now. Signing before the deadline means signing at the exact moment the market prices him lowest — after an injury-hit season, without a jump shot, on a sixty-loss team. Entering RFA after a healthy season means signing when there is the most information available. He surrenders security in exchange for the right to be paid correctly if he proves it. The largest discount Washington currently holds is not the injury history. It is that Coulibaly has never played a single playoff minute. Offer-sheet pricing for young wings is normally anchored on two-way survivability in a series where opponents target you. He has no sample. That asymmetry favors the team, not the player. The most uncomfortable part is the "steady development" label. That is the author's opinion, not a measured curve. For a fourth-year player, "steady" is the word people use when there is no leap to describe. In a contract year, steady is a neutral-to-negative signal. Teams pay for leaps, not for straight lines. The court needs someone seated beside the throne willing to say the king is wearing no clothes. Here the king is the narrative that Coulibaly is developing evenly. In my own game logs across three seasons, no number in that article backs it up. The variable next season is not scoring average. It is games played, and how many times opposing defenses dare to leave him beyond the arc. If both improve, Washington will have to pay market price for a player it just decided not to buy. If only one improves, they still sit above the table. And if neither does, they saved themselves a long contract — exactly the way a rebuilding team should save. An empty gym does not kill basketball; it only strips the makeup off the pretenders. Washington next season will be that empty gym: no standings pressure, no media expectation, nothing left but the bare question of whether he can shoot.